Palliative Care for Patients with Dementia
Launched by ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · Feb 18, 2023
Trial Information
Current as of October 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new type of in-home palliative care designed for patients with advanced dementia and their family caregivers. The goal is to see how well this care model helps improve the quality of life for both patients and their caregivers. Participants will be randomly assigned to either receive this specialized care or to a standard care option, allowing researchers to compare the two approaches.
To participate, individuals must be 64 years or older, have advanced dementia, and show difficulties with daily activities. They should also have had at least one hospitalization or emergency room visit in the past year, and they need to live in Manhattan with a family caregiver who is willing to take part in the study. It’s important that participants or their legal representatives can give consent and speak English or Spanish. Those who qualify can expect to receive support and resources tailored to their needs, which could help improve their overall well-being during this challenging time.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • have advanced dementia, based on Global Deterioration Score (GDS)\>6
- • impairment in at least one activity of daily living (ADL -which is inherent in this level of GDS)
- • at least one hospitalization or ED visit within the last 12 months
- • a physician who is primarily responsible for their dementia-related care whose clinical outpatient site is associated with one of the four Mount Sinai sites in Manhattan
- • a family caregiver willing to enroll
- • a residence in Manhattan where they are currently living (not in a long-term care facility)
- • capacity to consent or a legal representative available to provide consent
- • fluency in English or Spanish, or their legal representative must be fluent in English or Spanish
- • age \>64.
- Exclusion Criteria:
- • Does not have a family caregiver to enroll
- • Does not reside in Manhattan outside of long-term care facility
- • Does not have fluency in English or Spanish Doesn't
About Icahn School Of Medicine At Mount Sinai
The Icahn School of Medicine at Mount Sinai is a premier academic institution located in New York City, renowned for its commitment to advancing medical research, education, and patient care. As a leading sponsor of clinical trials, the institution leverages its state-of-the-art facilities and multidisciplinary expertise to drive innovative research initiatives aimed at improving health outcomes. With a focus on translational medicine, the Icahn School of Medicine collaborates with a diverse network of researchers, clinicians, and industry partners to explore novel therapies and interventions across a wide range of medical disciplines. Its rigorous scientific approach and dedication to ethical standards position it as a trusted leader in the clinical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Patients applied
Trial Officials
Laura P Gelfman, MD, MPH
Principal Investigator
Icahn School of Medicine at Mount Sinai
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials